Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release
- 1 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 317 (2-3) , R1-R2
- https://doi.org/10.1016/s0014-2999(96)00815-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Neurochemical and behavioural interactions between ibogaine and nicotine in the ratBritish Journal of Pharmacology, 1996
- Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activityPsychopharmacology, 1995
- Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatumBrain Research, 1994
- Nicotine Tolerance in Chromaffin Cell Cultures: Acute and Chronic Exposure to Smoking‐Related Nicotine DosesJournal of Neurochemistry, 1994
- Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studiesBrain Research, 1992
- The action of tabernanthine on noradrenaline-stimulated contractions and 45Ca movements in rat isolated vascular smooth muscleEuropean Journal of Pharmacology, 1983